Dialysis patients urge government to improve cardiovascular support

Patients living with end-stage renal disease are increasingly advocating for more robust cardiovascular care, pointing to a significant gap between their clinical needs and the information provided by healthcare systems. This movement, supported by personal accounts from those who have navigated the physical and emotional exhaustion of long-term treatment, seeks to address the heightened risks of heart attack and stroke that frequently accompany kidney failure.

According to Kidney Research UK, individuals with kidney disease are 6 times more likely to experience a major cardiac event than the general population. Data from the same organization suggests that approximately 20,000 kidney patients lose their lives to cardiac complications annually. Despite these figures, many patients describe a lack of communication regarding the intersection of renal and cardiovascular health. Lee Farrington, who began dialysis in 2022, reported being caught off guard by his subsequent cardiac emergencies. It was a shock because I’d never been told my kidney disease put me at risk of cardiovascular problems, Farrington stated.

Related imagery

The government unveiled a new cardiovascular disease strategy on 7 July. This policy aims to recognize the link between high blood pressure, heart disease, and renal failure, pledging to expand targeted testing for undiagnosed chronic kidney disease. Sir Stephen Powis, a trustee of Kidney Research UK and former medical director of NHS England, noted that the strategy has the once-in-a-generation potential to save thousands of kidney patients' lives. However, he emphasized that the success of these measures relies heavily on ensuring that general practitioners receive the necessary resources to manage this intersection of care and improve access to essential treatments.

The patient experience often extends beyond the clinic, as the rigid schedule of dialysis — typically 4 hours per session, 3 times per week — imposes significant lifestyle constraints. For some, this routine is a source of physical exhaustion that hampers employment and the ability to plan for the future. Advocacy efforts have increasingly been led by couples who met while navigating these clinical settings. Lee and Kacey Farrington, who met at the Cambridge Dialysis Centre in 2022, highlighted how their mutual understanding of the treatment’s rigors provided a vital support system. Similarly, Kimberlyn and Scott Myer, who met while awaiting transplants in 2012, have focused their advocacy on public awareness for organ donation, emphasizing that their lives were extended through the generosity of donors.

The psychological toll of these conditions has prompted new approaches to research and patient engagement. The Hemodialysis Pain Reduction Effort (HOPE) is one initiative that integrates patients onto steering committees to ensure that research priorities, such as generalized pain and the psychological burden of treatment, reflect real-world concerns. Participants like Dave, who shared his experiences through the HOPE study, have noted that being treated as active members of the research team has improved their quality of life. By participating in pain-coping strategies and sharing their Stories through recruitment media, these patients hope to provide a blueprint for more patient-centered medical trials.

For those managing chronic kidney disease, the path forward involves a complex balance of monitoring cardiovascular health, adhering to treatment schedules, and maintaining hope for a future transplant. As the government begins to implement its testing pledges, the medical community and patient advocates remain focused on how these policies will translate into local clinical practice. Future outcomes will depend on the ability of healthcare providers to better support patients in managing both their renal and cardiovascular health in tandem, ensuring that the patient voice remains central to ongoing research and policy reform.